SGLT1 is required for the survival of triple-negative breast cancer cells via potentiation of EGFR activity. [electronic resource]
- Molecular oncology 09 2019
- 1874-1886 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't